Essentiality and functional analysis of type I and type III pantothenate kinases of Mycobacterium tuberculosis

Microbiology

Volumn 156, Issue 9, 2010, Pages 2691-2701

  Awasthy, Disha ^a   Ambady, Anisha ^a   Bhat, Jyothi ^a   Sheikh, Gulebahar ^a   Ravishankar, Sudha ^a   Subbulakshmi, Venkita ^a   Mukherjee, Kakoli ^a   Sambandamurthy, Vasan ^a   Sharma, Umender ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PANTHOTHENATE KINASE; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; ESCHERICHIA COLI; GENE INACTIVATION; IN VITRO STUDY; MACROPHAGE FUNCTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING; TEMPERATURE SENSITIVITY;

ANIMALS; BACTERIAL PROTEINS; ISOENZYMES; KINETICS; MICE; MICE, INBRED BALB C; MYCOBACTERIUM TUBERCULOSIS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SEQUENCE DELETION; TUBERCULOSIS;

BACILLUS ANTHRACIS; CORYNEBACTERINEAE; ESCHERICHIA COLI; EUKARYOTA; MUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 77956385333     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.040717-0     Document Type: Article

References (36)

1. Awasthy, D., Gaonkar, S., Shandil, R. K., Yadav, R., Bharath, S., Marcel, N., Subbulakshmi, V. & Sharma, U. (2009). Inactivation of the ilvB1 gene in Mycobacterium tuberculosis leads to branched-chain amino acid auxotrophy and attenuation of virulence in mice. Microbiology 155, 2978-2987.
2. Brand, L. A. & Strauss, E. (2005). Characterization of a new pantothenate kinase isoform from Helicobacter pylori. J Biol Chem 280, 20185-20188.
3. Chan, E. D. & Iseman, M. D. (2008). Multidrug-resistant and extensively drug-resistant tuberculosis: a review. Curr Opin Infect Dis 21, 587-595.
4. Choudhry, A. E., Mandichak, T. L., Broskey, J. P., Egolf, R. W., Kinsland, C., Begley, T. P., Seefeld, M. A., Ku, T. W., Brown, J. R. & other authors (2003). Inhibitors of pantothenate kinase: novel antibiotics for staphylococcal infections. Antimicrob Agents Chemother 47, 2051-2055. (Pubitemid 36637845)
5. Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S. & other authors (1998). Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537-544. (Pubitemid 28319235)
6. Cole, S. T., Eiglmeier, K., Parkhill, J., James, K. D., Thomson, N. R., Wheeler, P. R., Honoré , N., Garnier, T., Churcher, C. & other authors (2001). Massive gene decay in the leprosy bacillus. Nature 409, 1007-1011.
7. Converse, P. J., Karakousis, P. C., Klinkenberg, L. G., Kesavan, A. K., Ly, L. H., Allen, S. S., Grosset, J. H., Jain, S. K., Lamichhane, G. & other authors (2009). Role of the dosR-dosS two-component regulatory system in Mycobacterium tuberculosis virulence in three animal models. Infect Immun 77, 1230-1237.
8. Das, S., Kumar, P., Bhor, V., Surolia, A. & Vijayan, M. (2006). Invariance and variability in bacterial PanK: a study based on the crystal structure of Mycobacterium tuberculosis PanK. Acta Crystallogr D Biol Crystallogr 62, 628-638. (Pubitemid 43806641)
9. Dunn, S. D. & Snell, E. E. (1979). Isolation of temperature-sensitive pantothenate kinase mutants of Salmonella typhimurium and mapping of the coaA gene. J Bacteriol 140, 805-808.
10. Gerdes, S. Y., Scholle, M. D., D'Souza, M., Bernal, A., Baev, M. V., Farrell, M., Kurnasov, O. V., Daugherty, M. D., Mseeh, F. & other authors (2002). From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathways. J Bacteriol 184, 4555-4572.
11. Guzman, L. M., Belin, D., Carson, M. J. & Beckwith, J. (1995). Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J Bacteriol 177, 4121-4130.
12. Hoft, D. F. (2008). Tuberculosis vaccine development: goals, immunological design, and evaluation. Lancet 372, 164-175.
13. Jackowski, S. & Rock, C. O. (1981). Regulation of coenzyme A biosynthesis. J Bacteriol 148, 926-932.
14. Kumar, P., Chhibber, M. & Surolia, A. (2007). How pantothenol intervenes in Coenzyme-A biosynthesis of Mycobacterium tuberculosis. Biochem Biophys Res Commun 361, 903-909. (Pubitemid 47259024)
15. Leonardi, R., Chohnan, S., Zhang, Y. M., Virga, K. G., Lee, R. E., Rock, C. O. & Jackowski, S. (2005). A pantothenate kinase from Staphylococcus aureus refractory to feedback regulation by coenzyme A. J Biol Chem 280, 3314-3322.
16. Liberati, N. T., Urbach, J. M., Miyata, S., Lee, D. G., Drenkard, E., Wu, G., Villanueva, J., Wei, T. & Ausubel, F. M. (2006). An ordered, non-redundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc Natl Acad Sci U S A 103, 2833-2838.
17. Muñoz-Elías, E. J. & McKinney, J. D. (2005). Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat Med 11, 638-644.
18. Nicely, N. I., Parsonage, D., Paige, C., Newton, G. L., Fahey, R. C., Leonardi, R., Jackowski, S., Mallett, T. C. & Claiborne, A. (2007). Structure of the type III pantothenate kinase from Bacillus anthracis at 2.0 A resolution: implications for coenzyme A-dependent redox biology. Biochemistry 46, 3234-3245.
19. Paige, C., Reid, S. D., Hanna, P. C. & Claiborne, A. (2008). The type III pantothenate kinase encoded by coaX is essential for growth of Bacillus anthracis. J Bacteriol 190, 6271-6275.
20. Parish, T. & Stoker, N. G. (2000). Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement. Microbiology 146, 1969-1975.
21. Parish, T., Lewis, J. & Stoker, N. G. (2001). Use of the mycobacteriophage L5 excisionase in Mycobacterium tuberculosis to demonstrate gene essentiality. Tuberculosis (Edinb) 81, 359-364.
22. Rivers, E. C. & Mancera, R. L. (2008). New anti-tuberculosis drugs in clinical trials with novel mechanisms of action. Drug Discov Today 13, 1090-1098.
23. Rock, C. O., Park, H. W. & Jackowski, S. (2003). Role of feedback regulation of pantothenate kinase (CoaA) in control of coenzyme A levels in Escherichia coli. J Bacteriol 185, 3410-3415.
24. Saliba, K. J., Ferru, I. & Kirk, K. (2005). Provitamin B5 (pantothenol) inhibits growth of the intraerythrocytic malaria parasite. Antimicrob Agents Chemother 49, 632-637.
25. Snell, E. E. & Shive, W. (1945). Growth inhibition by analogues of pantothenic acid. Pantothenyl alcohol and related compounds. J Biol Chem 158, 551-559.
26. Spry, C., Chai, C. L., Kirk, K. & Saliba, K. J. (2005). A class of pantothenic acid analogs inhibits Plasmodium falciparum pantothenate kinase and represses the proliferation of malaria parasites. Antimicrob Agents Chemother 49, 4649-4657.
27. Spry, C., Kirk, K. & Saliba, K. J. (2008). Coenzyme A biosynthesis: an antimicrobial drug target. FEMS Microbiol Rev 32, 56-106.
28. Sun, R., Converse, P. J., Ko, C., Tyagi, S., Morrison, N. E. & Bishai, W. R. (2004). Mycobacterium tuberculosis ECF sigma factor sigC is required for lethality in mice and for the conditional expression of a defined gene set. Mol Microbiol 52, 25-38.
29. Vallari, D. S. & Rock, C. O. (1987). Isolation and characterization of temperature-sensitive pantothenate kinase (coaA) mutants of Escherichia coli. J Bacteriol 169, 5795-5800.
30. Wards, B. J. & Collins, D. M. (1996). Electroporation at elevated temperatures substantially improves transformation efficiency of slow-growing mycobacteria. FEMS Microbiol Lett 145, 101-105.
31. Wood, G. E. & Friedman, R. L. (2000). The Bvg accessory factor (Baf) enhances pertussis toxin expression in Escherichia coli and is essential for Bordetella pertussis viability. FEMS Microbiol Lett 193, 25-30.
32. Yang, K., Eyobo, Y., Brand, L. A., Martynowski, D., Tomchick, D., Strauss, E. & Zhang, H. (2006). Crystal structure of a type III pantothenate kinase: insight into the mechanism of an essential coenzyme A biosynthetic enzyme universally distributed in bacteria. J Bacteriol 188, 5532-5540.
33. Yang, K., Strauss, E., Huerta, C. & Zhang, H. (2008). Structural basis for substrate binding and the catalytic mechanism of type III pantothenate kinase. Biochemistry 47, 1369-1380.
34. Yocum, R. R. & Patterson, T. A. (2004). US Patent 6,830,898.
35. Zhang, Y. M., Frank, M. W., Virga, K. G., Lee, R. E., Rock, C. O. & Jackowski, S. (2004). Acyl carrier protein is a cellular target for the antibacterial action of the pantothenamide class of pantothenate antimetabolites. J Biol Chem 279, 50969-50975.
36. Zhao, L., Allanson, N. M., Thomson, S. P., Maclean, J. K., Barker, J. J., Primrose, W. U., Tyler, P. D. & Lewendon, A. (2003). Inhibitors of phosphopantetheine adenylyltransferase. Eur J Med Chem 38, 345-349.